Medical technology has traditionally been built around hospitals. Procurement teams, clinical workflows and regulatory milestones have shaped what products look like, how they launch and who they serve. But today that model is slowly but surely being overturned.
The next wave of medtech adoption is not being driven solely by health systems, but by people – in their homes, in their routines and through their lifestyle choices.
From wellness tools to direct-to-consumer diagnostics and regulated medical devices, innovation is moving upstream towards everyday life. And with it, the rules of success are changing.
Of course technology and clinical evidence will always be of paramount importance. But neither is enough on its own anymore. The companies winning in medtech today are those that understand consumer behaviour just as deeply as they understand physiology.
New rules of engagement
We’re witnessing a structural shift in where health happens. Remote monitoring, at-home testing, preventative self-care and performance optimisation are no longer fringe behaviours. People increasingly expect to engage with their health the same way they engage with banking, fitness or
nutrition – on their terms and integrated into daily life.
This has huge implications for medtech design teams.
When a product lives in a hospital, usage is driven by protocol. When it lives in the home, it’s driven by motivation, identity and habit. If it feels intimidating, stigmatising or inconvenient, it’s much less likely to be used, no matter how effective the technology is.
This is why consumer blood pressure monitors now look more like wearable tech than medical equipment. It’s why at-home test kits arrive in packaging that resembles skincare rather than lab supplies. And it’s why entire categories of preventative health are being prioritised by consumers
(Mintel).
From wellness to medicine
The fact that the FDA felt the need to issue updated guidance – General Wellness: Policy for Low Risk Devices – shows how blurred the line between wellness products and medical devices can be. However the guidance indicates that some products, including those that are focused on ‘maintaining
or encouraging a general state of health or a healthy activity’, may not face the same regulatory burden as medical devices.
This distinction is underpinning a new generation of consumer-led health innovation. It allows founders to start with general wellness, build trust and data, generate revenue and later expand their offer into regulated medical territory once they have already seen commercial success. Many of today’s fastest-growing health related brands already follow this path.
Why experience matters
One of the biggest changes we see as product designers is the shift in how health products are being framed.
Historically, medtech has centred on what’s wrong – disease, dysfunction. Consumer-led health flips this narrative towards capability, confidence and quality of life.
One example is Symoréa, a skin microbiome testing concept currently in development. We designed it to mirror the structure of a skincare ritual. It moves away from the idea of a one-off, clinical-looking test and instead becomes part of a mindful self-care routine – something users look forward to rather than simply tolerate.
Another standout example is Malebox, an at-home sperm testing kit designed to feel intuitive, premium and empowering. Tone partnered with Malebox to create a seamless packaging experience supported by clear, user-friendly instructions. While we navigated practical challenges such as
refrigeration and sample handling, our larger goal was to reframe the journey towards something elevated, modern and confidence-building.
Similarly, Supersapiens repurposed continuous glucose monitoring from diabetes management into a performance and nutrition optimisation tool for athletes. Same core technology. Completely different relationship with the user.
In these cases, a key driver for adoption is in the way the product fits into everyday life, how it looks, how it makes people feel.
This is an important lesson for medtech companies – people don’t just buy health outcomes, they buy identity.
Consumer brands are now the competition
Another reality many medical founders underestimate is who they’re competing with. In the direct-to-consumer space, medtech isn’t just competing with other regulated devices. It’s competing with Apple, Peloton, Oura, premium skincare brands and beautifully designed wellness products. These companies are experts in user experience, storytelling, ritual and emotional connection.
If your health product feels confusing, ugly or burdensome by comparison, it won’t stand a chance, even if the science is exceptional.
We regularly see breakthrough technologies struggle because the product experience feels like hospital equipment transplanted into the home. Great technology doesn’t market itself and it certainly doesn’t integrate itself into daily life.
The new competitive advantage
The future of medtech will still be built on robust science, of course. But success will belong to the companies that merge clinical credibility, consumer-grade design, emotional resonance and lifestyle integration.
Hospitals will always matter, but they’re no longer the sole gatekeepers of adoption because health is becoming personal, preventative and participatory.
As it does, the most powerful innovations won’t feel like medical devices at all. They’ll feel like tools that help people live the lives they aspire to.
